Epizyme
-$0.06 (-0.87%) As of 7:12 PM UTC today
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Epizyme and other ETFs, options, and stocks.
About EPZM
Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases.
CEO
Robert B. Bazemore
Employees
304
Headquarters
Cambridge, Massachusetts
Founded
2007
EPZM Key Statistics
Market Cap
881.00M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
978.98K
High Today
$7.01
Low Today
$6.73
Open Price
$6.93
Volume
397.13K
52 Week High
$14.74
52 Week Low
$6.49
Analyst Ratings
75%
of 8 ratings
Buy
75%
Hold
25%
Sell
0%
EPZM Earnings
-$0.74
-$0.49
-$0.25
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 10, Pre-Market